179 related articles for article (PubMed ID: 17893877)
1. The activities of progesterone receptor isoform A and B are differentially modulated by their ligands in a gene-selective manner.
Leo JC; Lin VC
Int J Cancer; 2008 Jan; 122(1):230-43. PubMed ID: 17893877
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of mixed properties of RU486 in progesterone receptor (PR)-transfected MDA-MB-231 cells: a model for studying the functions of progesterone analogues.
Lin VC; Aw SE; Ng EH; Ng EH; Tan MG
Br J Cancer; 2001 Dec; 85(12):1978-86. PubMed ID: 11747343
[TBL] [Abstract][Full Text] [Related]
3. Agonist and antagonist-induced qualitative and quantitative alterations of progesterone receptor from breast cancer cells.
Hurd C; Nag K; Khattree N; Alban P; Dinda S; Moudgil VK
Mol Cell Biochem; 1999 Sep; 199(1-2):49-56. PubMed ID: 10544951
[TBL] [Abstract][Full Text] [Related]
4. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
Sumida T; Itahana Y; Hamakawa H; Desprez PY
Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
[TBL] [Abstract][Full Text] [Related]
5. Progesterone induces focal adhesion in breast cancer cells MDA-MB-231 transfected with progesterone receptor complementary DNA.
Lin VC; Ng EH; Aw SE; Tan MG; Ng EH; Bay BH
Mol Endocrinol; 2000 Mar; 14(3):348-58. PubMed ID: 10707953
[TBL] [Abstract][Full Text] [Related]
6. Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology.
Jacobsen BM; Schittone SA; Richer JK; Horwitz KB
Mol Endocrinol; 2005 Mar; 19(3):574-87. PubMed ID: 15563544
[TBL] [Abstract][Full Text] [Related]
7. Nuclear progesterone receptor A and B isoforms in mouse fallopian tube and uterus: implications for expression, regulation, and cellular function.
Shao R; Weijdegård B; Ljungström K; Friberg A; Zhu C; Wang X; Zhu Y; Fernandez-Rodriguez J; Egecioglu E; Rung E; Billig H
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E59-72. PubMed ID: 16449295
[TBL] [Abstract][Full Text] [Related]
8. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
[TBL] [Abstract][Full Text] [Related]
9. An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestin-induced transcriptional activity.
Wei LL; Hawkins P; Baker C; Norris B; Sheridan PL; Quinn PG
Mol Endocrinol; 1996 Nov; 10(11):1379-87. PubMed ID: 8923464
[TBL] [Abstract][Full Text] [Related]
10. New antiprogestins with partial agonist activity: potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties.
Giannoukos G; Szapary D; Smith CL; Meeker JE; Simons SS
Mol Endocrinol; 2001 Feb; 15(2):255-70. PubMed ID: 11158332
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms controlling agonist and antagonist potential of selective progesterone receptor modulators (SPRMs).
Wardell SE; Edwards DP
Semin Reprod Med; 2005 Feb; 23(1):9-21. PubMed ID: 15714386
[TBL] [Abstract][Full Text] [Related]
12. Differential role of PR-A and -B isoforms in transcription regulation of human GnRH receptor gene.
Cheng KW; Cheng CK; Leung PC
Mol Endocrinol; 2001 Dec; 15(12):2078-92. PubMed ID: 11731610
[TBL] [Abstract][Full Text] [Related]
13. Differential response of progesterone receptor isoforms in hormone-dependent and -independent facilitation of female sexual receptivity.
Mani SK; Reyna AM; Chen JZ; Mulac-Jericevic B; Conneely OM
Mol Endocrinol; 2006 Jun; 20(6):1322-32. PubMed ID: 16484336
[TBL] [Abstract][Full Text] [Related]
14. [Functional study of progesterone receptor isoforms in endometrial cancer cell lines].
Lu Y; Liao QP; Chen CL; Yu L
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):475-9. PubMed ID: 17068617
[TBL] [Abstract][Full Text] [Related]
15. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.
Sartorius CA; Groshong SD; Miller LA; Powell RL; Tung L; Takimoto GS; Horwitz KB
Cancer Res; 1994 Jul; 54(14):3868-77. PubMed ID: 8033109
[TBL] [Abstract][Full Text] [Related]
16. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.
Gass EK; Leonhardt SA; Nordeen SK; Edwards DP
Endocrinology; 1998 Apr; 139(4):1905-19. PubMed ID: 9528977
[TBL] [Abstract][Full Text] [Related]
17. Distinct temporal and spatial activities of RU486 on progesterone receptor function in reproductive organs of ovariectomized mice.
Han SJ; Tsai SY; Tsai MJ; O'Malley BW
Endocrinology; 2007 May; 148(5):2471-86. PubMed ID: 17303655
[TBL] [Abstract][Full Text] [Related]
18. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay.
Leonhardt SA; Altmann M; Edwards DP
Mol Endocrinol; 1998 Dec; 12(12):1914-30. PubMed ID: 9849965
[TBL] [Abstract][Full Text] [Related]
19. Ulipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human Breast Cancer Proliferation and BCl2-L1 Expression.
Esber N; Le Billan F; Resche-Rigon M; Loosfelt H; Lombès M; Chabbert-Buffet N
PLoS One; 2015; 10(10):e0140795. PubMed ID: 26474308
[TBL] [Abstract][Full Text] [Related]
20. Coactivator/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486.
Liu Z; Auboeuf D; Wong J; Chen JD; Tsai SY; Tsai MJ; O'Malley BW
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):7940-4. PubMed ID: 12048256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]